Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8753660

    Activating extraction of demineralized bone matrix

    The Regents of the University of California · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8754034

    Structure-based design of peptide inhibitors of amyloid fibrillation

    The Regents of the University of California · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8754044

    Neuroprotection by hepatic cells and hepatocyte secretory factors

    Northwestern University · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8753682

    Dual release oral tablet compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8754051

    Peptide modulators of the δPKC interaction with the d subunit of F1Fo ATP synthase/ATPase and uses thereof

    Georgia Regents Research Institute, Inc. · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8754050

    Macrocyclic compounds useful as inhibitors of histone deacetylases

    The Regents of the University of Colorado · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8754081

    Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8754124

    Oligo-benzamide compounds and their use in treating cancers

    The Board of Regents of the University of Texas System · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8754201

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8753646

    IPV-DPT vaccine

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8754222

    Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8754564

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8754225

    Process for preparing a biphenyl-2-ylcarbamic acid

    Theravance, Inc. · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8754108

    Freeze-dried pantoprazole preparation and pantoprazole injection

    TAKEDA GMBH · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8754223

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8754224

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8754233

    Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

    Dermira (Canada), Inc. · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8758311

    Transdermal patch with extensor means

    Nemaura Pharma Limited · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8758778

    Polymeric nano-carriers with a linear dual response mechanism and uses thereof

    The Regents of the University of California · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8758799

    Therapeutic implant

    Covidien LP · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8758800

    Therapeutic implant

    Covidien LP · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8758798

    Therapeutic implant

    Covidien LP · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8758796

    Functionalizing implantable devices with a poly (diol citrate) polymer

    Northwestern University · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8758755

    Stem cell fusion model of carcinogenesis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8759284

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8758818

    Oral tablet compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8759006

    PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia

    The Regents of the University of California · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8758817

    Dosage form containing (S)-pantoprazole as active ingredient

    TAKEDA GMBH · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8759014

    Methods of obtaining antigen-specific T cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8759296

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8759302

    Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8759492

    Engineered red-shifted channelrhodopsin variants

    The Regents of the University of California · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8759389

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8759318

    Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections

    University College Cardiff Consultants Limited · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8759327

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8759325

    Compositions and methods of treatment for inflammatory diseases

    The Regents of the University of Oklahoma · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8759353

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8759335

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8759392

    Amides as inhibitors of human secreted phospholipase A2

    The Regents of the University of California · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8758813

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8758723

    Compositions and methods for cellular imaging and therapy

    The Board of Regents of the University of Texas System · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8759340

    Benzodiazepinone compounds useful in the treatment of skin conditions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8759332

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8759314

    Methods for treating multiple sclerosis using antisense oligonucleotides

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8759301

    Gene fusion targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8764828

    System and method for forming bone, ligament, and bone-ligament constructs

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8765147

    Endophytic fungi from Pteromischum sp. plant, compounds and methods of use

    The Regents of the University of California · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8765717

    Meloxicam and glucosamine formulation and uses thereof

    Monte Verde S.A. · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.